EPISODIC MIGRAINE
Clinical trials for EPISODIC MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new EPISODIC MIGRAINE trials appear
Sign up with your email to follow new studies for EPISODIC MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with migraines? drug trial aims to cut monthly headaches
Disease control OngoingThis study tests if galcanezumab can prevent migraines in children aged 6 to 17 with episodic migraine. About 533 participants will receive either the drug or a placebo for 3 months. The main goal is to see if the drug reduces the number of migraine days each month.
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
Botox-Like shots aim to stop migraines before they start
Prevention OngoingThis study tests whether Dysport, a botulinum toxin type A injection, can prevent episodic migraines (fewer than 15 headache days per month) in adults. About 751 participants will receive either Dysport or a placebo injected into head, neck, and shoulder muscles over 24 weeks, fo…
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE3 • Sponsor: Ipsen • Aim: Prevention
Last updated May 17, 2026 06:38 UTC